Table 3 Histopathological characteristics according to ATA guidelines in the subgroup patients with pre-operative indeterminate or positive cytology for malignant disease
All patients (2014–2016) | 28/197 (14.2%) |
|---|---|
Nodules ≤1 cm | 13/28 (46.4%) |
Solitary nodule | 3/28 (10.7%) |
Age < 40 y | 4/28 (14.3%) |
No capsule invasion | 26/28 (92.9%) |
No metastatic lymphadenopaties | 26/28 (92.8%) |
Radiant therapy | 0/28 (0%) |
Patients satisfying all ATA parameters for Istmo-lobectomy | 1/28 (3.6%) |